{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:52:09Z","timestamp":1792133529770,"version":"4.4.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.preteyeres.2010.08.002","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T04:31:42Z","timestamp":1283833902000},"page":"596-609","source":"Crossref","is-referenced-by-count":342,"title":["Applications of nanoparticles in ophthalmology"],"prefix":"10.1016","volume":"29","author":[{"given":"Yolanda","family":"Diebold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Calonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2010.08.002_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addr.2009.03.009","article-title":"Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1163\/156856209X418519","article-title":"pH-dependent disruption of erythrocyte membrane by amphiphilic poly(amino acid) nanoparticles","volume":"21","author":"Akagi","year":"2010","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1211\/0022357022476","article-title":"The potential of chitosan in ocular drug delivery","volume":"55","author":"Alonso","year":"2003","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib5","first-page":"150","article-title":"Effect of circulation on the disposition and ocular tissue distribution of 20\u00a0nm nanoparticles after periocular administration","volume":"14","author":"Amrite","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/02713680903017500","article-title":"Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea","volume":"34","author":"Attama","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","article-title":"Endocytic mechanisms for targeted drug delivery","volume":"59","author":"Bareford","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0031-6865(97)00021-6","article-title":"Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations","volume":"72","author":"Bayens","year":"1997","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib9","first-page":"124","article-title":"Nanoparticles for gene delivery to retinal pigment epithelial cells","volume":"11","author":"Bejjani","year":"2005","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.gt.3302030","article-title":"Immune following intraocular delivery of recombinant viral vectors","volume":"10","author":"Bennett","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib11","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.addr.2006.07.023","article-title":"Non-viral ocular gene therapy: potential ocular therapeutic avenues","volume":"58","author":"Bloquel","year":"2006","journal-title":"Adv. Drug Deliv. Revs."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0014-4835(03)00030-7","article-title":"Recent developments in ocular gene therapy","volume":"76","author":"Borr\u00e1s","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib133","first-page":"2513","article-title":"Gene therapy for glaucoma: treating a multifaceted, chronic disease","volume":"43","author":"Borr\u00e1s","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib13","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1167\/iovs.02-1068","article-title":"Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles","volume":"44","author":"Bourges","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib14","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1016015803611","article-title":"Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A","volume":"13","author":"Calvo","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14712598.2.5.537","article-title":"Gene therapy for retinal and choroidal diseases","volume":"2","author":"Campochiaro","year":"2002","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.gt.3302653","article-title":"Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders","volume":"13","author":"Campochiaro","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib19","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nnano.2006.91","article-title":"Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides","volume":"1","author":"Chen","year":"2006","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1389201003378852","article-title":"Controlled delivery of biotechnological products","volume":"1","author":"Conti","year":"2000","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/ICO.0b013e3181bd9eee","article-title":"Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles","volume":"29","author":"Contreras-Ruiz","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-5793(77)80717-5","article-title":"Nanocapsules: a new type of lysomotropic carrier","volume":"84","author":"Couvreur","year":"1977","journal-title":"FEBS Lett."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib24","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.biomaterials.2006.11.036","article-title":"Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons","volume":"28","author":"Das","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/B:PHAM.0000026432.75781.cb","article-title":"Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in\u00a0vivo fate, and cellular toxicity","volume":"21","author":"de Campos","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporine A","volume":"224","author":"de Campos","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0928-0987(03)00178-7","article-title":"The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa","volume":"20","author":"de Campos","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/mabi.200700190","article-title":"Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules","volume":"8","author":"de la Fuente","year":"2008","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib29","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1167\/iovs.07-1077","article-title":"Novel hyaluronic acid-chitosan nanoparticles for ocular gene delivery","volume":"49","author":"de la Fuente","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems. A shift to the posterior segment","volume":"13","author":"del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib136","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.04.023","article-title":"Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells","volume":"360","author":"del Pozo-Rodr\u00edguez","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib31","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.biomaterials.2006.11.028","article-title":"Ocular drug delivery by liposome\u2013chitosan nanoparticle complexes (LCS-NP)","volume":"28","author":"Diebold","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0007410","article-title":"Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina","volume":"4","author":"Ding","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/mp800032f","article-title":"Preclinical studies to understand nanoparticles interaction with the immune system and its potential effects on nanoparticles biodistribution","volume":"5","author":"Dobrovolskaia","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/138161207779313795","article-title":"Controlled delivery of peptides and proteins","volume":"13","author":"Degim","year":"2007","journal-title":"Curr.\u00a0Pharm. Des."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib36","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1023\/A:1013061926851","article-title":"Predicted permeability of the corneal to topical drugs","volume":"18","author":"Edwards","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib37","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1167\/iovs.05-0495","article-title":"Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance","volume":"47","author":"Enr\u00edquez-de-Salamanca","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib38","unstructured":"European Science Foundation Forward Look on Nanomedicine. http:\/\/www.esf.org\/publications\/forward-looks.html."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000038","article-title":"Efficient non-viral ocular gene transfer with compacted DNA nanoparticles","volume":"1","author":"Farjo","year":"2006","journal-title":"PLoS ONE"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib40","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.addr.2006.07.020","article-title":"Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA","volume":"58","author":"Fattal","year":"2006","journal-title":"Adv. Drug Dev. Rev."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2008.06.011","article-title":"State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers","volume":"364","author":"Fattal","year":"2008","journal-title":"Intl. J. Pharm."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib157","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.addr.2008.03.007","article-title":"Ultrasound mediated delivery of drugs and genes to solid tumors","volume":"30","author":"Frenkel","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib42","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment diseases","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv. Drug Deliv. Revs."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib44","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1566523034578285","article-title":"From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy","volume":"3","author":"Grimm","year":"2003","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib46","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1016\/j.biomaterials.2009.08.008","article-title":"Antiangiogenic properties of silver nanoparticles","volume":"30","author":"Gurunathan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib47","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.biomaterials.2008.03.014","article-title":"The role of cerium redox state in the SOD mimetic activity of nanoceria","volume":"29","author":"Heckert","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib48","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v25.i6.10","article-title":"Nanoparticle-cell interactions: drug delivery implications","volume":"25","author":"Harush-Frenkel","year":"2008","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10384-009-0655-x","article-title":"Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye","volume":"53","author":"Hayashi","year":"2009","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0167-4781(90)90031-V","article-title":"Specific regulation of gene expression of by antisense, sense and antigenic nucleic acids","volume":"1049","author":"Helene","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib52","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tips.2004.08.003","article-title":"Setting sights on the treatment of ocular angiogenesis using antisense oligonucleotides","volume":"25","author":"Henry","year":"2004","journal-title":"TRENDS Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.gt.3301983","article-title":"Progress and prospects: naked DNA gene transfer and therapy","volume":"10","author":"Herweijer","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib54","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers\u2019 entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0142-9612(01)00127-2","article-title":"Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide","volume":"23","author":"Hsiue","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1389557053175335","article-title":"Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs","volume":"5","author":"Irache","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"Jarvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib134","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.mt.6300324","article-title":"Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea","volume":"16","author":"Johnson","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1076\/ceyr.17.1.39.5251","article-title":"Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection model in the rat","volume":"17","author":"Juber\u00edas","year":"1998","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.gt.3302475","article-title":"Nonviral ocular gene transfer","volume":"12","author":"Kachi","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib59","first-page":"179","article-title":"Characterization of pilocarpine-loaded chitosan\/carbopol nanoparticles","volume":"58","author":"Kao","year":"2006","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2007.03.011","article-title":"Nanosuspensions as an ophthalmic delivery system for certain glucocorticoid drugs","volume":"340","author":"Kassem","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/DDC-120003445","article-title":"Ocular preparations: the formulation approach","volume":"28","author":"Kaur","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jps.2600800113","article-title":"Limits on optimizing ocular drug delivery","volume":"80","author":"Keister","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib63","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1163\/1568562042368112","article-title":"Formulation of chitosan-DNA nanoparticles with poly(propyl acrylic acid) enhances gene expression","volume":"15","author":"Kiang","year":"2004","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib64","doi-asserted-by":"crossref","first-page":"505101","DOI":"10.1088\/0957-4484\/20\/50\/505101","article-title":"Intravenously administered gold nanoparticles pass through the blood\u2013retinal barrier depending on the particle size, and induce no retinal toxicity","volume":"20","author":"Kim","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib65","doi-asserted-by":"crossref","first-page":"L696","DOI":"10.1152\/ajplung.00277.2005","article-title":"Smaller is not always better: nanotechnology yields nanotoxicology","volume":"289","author":"Kipen","year":"2005","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib66","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.biomaterials.2009.10.031","article-title":"Ultrapure chitosan oligomers as carriers for corneal gene transfer","volume":"31","author":"Klausner","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib67","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pharmthera.2005.03.004","article-title":"RNA interference: from gene silencing to gene-specific therapeutics","volume":"107","author":"Leung","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib68","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tibtech.2008.04.006","article-title":"Nanotechnology and aptamers: applications in drug delivery","volume":"26","author":"Levy-Nissenbaum","year":"2008","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/02652048609031575","article-title":"Ocular drug delivery of progesterone using nanoparticles","volume":"3","author":"Li","year":"1986","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib70","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1073\/pnas.86.10.3474","article-title":"Characterization of oligonucleotide transport into living cells","volume":"86","author":"Loke","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib71","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1023\/A:1018977130559","article-title":"Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol","volume":"10","author":"Losa","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib72","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.2042-7158.1991.tb03534.x","article-title":"Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles","volume":"43","author":"Losa","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib73","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib74","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood\u2013retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1046-2023(02)00232-3","article-title":"Gene delivery to the eye using adeno-associated viral vectors","volume":"28","author":"Martin","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib76","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1189\/jlb.0205074","article-title":"Nanotechnology for the biologist","volume":"78","author":"McNeil","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib77","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjp.0707130","article-title":"Nanoparticles: pharmacological and toxicological significance","volume":"150","author":"Medina","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0928-0987(00)00169-X","article-title":"Ganciclovir-loaded nanoparticles: characterization and in vitro release properties","volume":"12","author":"Merodio","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10611860290022660","article-title":"Efficacy of ganciclovir-loaded nanoparticles in human cytomegalovirus (HCMV)-infected cells","volume":"10","author":"Merodio","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib138","first-page":"746","article-title":"Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene","volume":"23","author":"Mo","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib80","first-page":"513","article-title":"Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation","volume":"68","author":"Motwani","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib81","unstructured":"National Characterization Laboratory, U.S. National Cancer Institute. http:\/\/ncl.cancer.gov\/working_assay-cascade.asp, (accessed June 2010)."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib82","unstructured":"National Institutes of Health of the U.S.A., Nanomedicine Roadmap Initiative. http:\/\/nihroadmap.nih.gov\/nanomedicine\/."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev.med.56.062904.144915","article-title":"Aptamers: an emerging class of therapeutics","volume":"56","author":"Nimjee","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib84","first-page":"184","article-title":"VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo","volume":"11","author":"Normand","year":"2005","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib85","doi-asserted-by":"crossref","first-page":"15042","DOI":"10.1074\/jbc.M010294200","article-title":"Particle formation by a conserved domain of the Herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery","volume":"276","author":"Normand","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/eye.1997.55","article-title":"Perspectives on gene therapy in the treatment of ocular inflammation","volume":"11","author":"Nussenblatt","year":"1997","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/toxsci\/kfp057","article-title":"Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice","volume":"109","author":"Nygaard","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2007.06.009","article-title":"Gold nanoparticles enable selective light-induced contents release from liposomes","volume":"11","author":"Paasonen","year":"2007","journal-title":"J. Control Release"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib89","doi-asserted-by":"crossref","unstructured":"Pan, T., Brown, D.J., Ziaie, B., 2006. An artificial nano-drainage implant (ANDI) for glaucoma treatment. In: Conf. Proc. IEEE Eng. Med. Biol. Soc., vol. 1, pp. 3174\u20133177.","DOI":"10.1109\/IEMBS.2006.260147"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib90","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.envpol.2008.12.028","article-title":"Single walled carbon nanotube reactivity and cytotoxicity following extended aqueous exposure","volume":"157","author":"Panessa-Warren","year":"2009","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib91","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/17425240902762818","article-title":"Chitosan nanoparticles for drug delivery to the eye","volume":"6","author":"Paolicelli","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib92","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/db08-1327","article-title":"Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularisation and diabetes-induced retinal vascular leakage","volume":"58","author":"Park","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib93","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1167\/iovs.05-0165","article-title":"Vitreous: a barriers to nonviral ocular gene therapy","volume":"46","author":"Peeters","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib94","doi-asserted-by":"crossref","first-page":"035102","DOI":"10.1088\/0957-4484\/21\/3\/035102","article-title":"Nanoceria have no genotoxic effect on human lens epithelial cells","volume":"21","author":"Pierscionek","year":"2010","journal-title":"Nanotechnology"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib95","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0928-0987(02)00057-X","article-title":"Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen","volume":"16","author":"Pignatello","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib96","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","article-title":"Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles","volume":"2","author":"Pinto-Reis","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib97","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00253-005-0193-5","article-title":"Aptamers-basic research, drug development, and clinical applications","volume":"69","author":"Proske","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib98","article-title":"Toxicity of nanomaterials to the eye","author":"Prow","year":"2009","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib99","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1472-8206.2003.00181.x","article-title":"Assessing immunotoxicity: guidelines","volume":"17","author":"Putman","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib141","first-page":"559","article-title":"Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: Role in PLGA nanoparticle Endocytosis","volume":"9","author":"Qaddoumi","year":"2003","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib101","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0958-1669(98)80031-1","article-title":"Adeno-associated virus expression systems for gene transfer","volume":"9","author":"Rabinowitz","year":"1998","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/CS20050158","article-title":"Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors","volume":"110","author":"Ralph","year":"2006","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib103","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib139","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/hum.2010.041","article-title":"Ocular gene therapy: an evaluation of recombinant adeno-associated virus-mediated gene therapy interventions for the treatment of ocular disease","volume":"21","author":"Roy","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib104","first-page":"A606","article-title":"Cerium oxide nanoparticles increase the lifespan of cultured brain cells and protect against free radical and mechanical trauma","volume":"17","author":"Rzigalinski","year":"2003","journal-title":"FASEB J."},{"issue":"3\/4","key":"10.1016\/j.preteyeres.2010.08.002_bib105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","article-title":"Nanotechnology in ocular drug delivery","author":"Sahoo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nano.2006.11.008","article-title":"The present and future of nanotechnology in human health care","volume":"3","author":"Sahoo","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib106","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.exer.2005.09.003","article-title":"Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate","volume":"82","author":"Sakai","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib107","series-title":"Nanoparticulates as Drug Carriers","isbn-type":"print","first-page":"1","article-title":"Nanoparticular carriers for ocular drug delivery","author":"S\u00e1nchez","year":"2006","ISBN":"https:\/\/id.crossref.org\/isbn\/1860946305"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v16.i1.20","article-title":"Enhancement of ocular drug penetration","volume":"16","author":"Sasaki","year":"1999","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib109","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003088-199018040-00001","article-title":"Ocular drug delivery: pharmacokinetics considerations","volume":"18","author":"Schoenwald","year":"1990","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.yrtph.2004.08.007","article-title":"Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development?","volume":"40","author":"Snodin","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib111","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1521-2254(199905\/06)1:3<166::AID-JGM34>3.0.CO;2-Z","article-title":"Adeno-associated virus-mediated gene delivery","volume":"1","author":"Snyder","year":"1999","journal-title":"J. Gene Med."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J. Control Release"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib113","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/10408440903120975","article-title":"Development of in vitro systems for nanotoxicology: methodological considerations","volume":"39","author":"Stone","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib114","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/08982100701375118","article-title":"Animal models of complement-mediated hypersensitivity reactions to liposomes and other liposome-based nanoparticles","volume":"17","author":"Szebeni","year":"2007","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib115","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/nl052024f","article-title":"Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage","volume":"12","author":"Tarnuzzer","year":"2005","journal-title":"Nano Lett."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib116","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2144\/97233st06","article-title":"Controlled gene gun delivery and expression of DNA within the cornea","volume":"23","author":"Tanelian","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib117","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0536.2008.01340.x","article-title":"A\u00a0case of toxic epidermal necrolysis-like dermatitis evolving from contact dermatitis of the hands associated with exposure to dendrimers","volume":"59","author":"Toyama","year":"2008","journal-title":"Contact Derm."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib118","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Revs."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/17435889.2.1.11","article-title":"Ocular drug delivery: nanomedicines application","volume":"2","author":"Vanderwoot","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib120","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/jps.20685","article-title":"Flurbiprofen loaded biodegradable nanoparticles for ophthalmic administration","volume":"95","author":"Vega","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib121","article-title":"Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation","author":"Wadhawa","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib122","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-5173(85)90007-9","article-title":"Ocular disposition of poly-hexyl-2-cyano(3-14C)acrylate nanoparticles in the albino rabbit","volume":"23","author":"Wood","year":"1985","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib123","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1023\/A:1007517912927","article-title":"Permeability and diffusion in vitreous humour: implications for drug delivery","volume":"17","author":"Xu","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib124","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1109\/TNB.2007.891883","article-title":"Visualizing vitreous using quantum dots as imaging agents","volume":"6","author":"Yamamoto","year":"2007","journal-title":"IEEE Trans. Nanobioscience"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3181\/0810-RM-304","article-title":"Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"234","author":"Yanagisawa","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/039463201002300112","article-title":"Size effects of polystyrene nanoparticles on atopic dermatitis-like skin lesions in NC\/NGA mice","volume":"23","author":"Yanagisawa","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib127","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2008.04.002","article-title":"Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea","volume":"87","author":"Yenice","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib128","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ymthe.2003.08.001","article-title":"VP22-mediated and light-activated delivery of anti-c-raf1 antisense oligonucleotide improves its activity after intratumoral injection in nude mice","volume":"8","author":"Zavaglia","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/1389450043345371","article-title":"Development of new drugs in angiogenesis","volume":"5","author":"Ziche","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.preteyeres.2010.08.002_bib130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/02652049109021873","article-title":"Studies on the transport pathway of PBCA nanoparticles in ocular tissues","volume":"8","author":"Zimmer","year":"1991","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib131","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1023\/A:1018995923348","article-title":"Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system","volume":"11","author":"Zimmer","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2010.08.002_bib132","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/en.2009-1082","article-title":"Minireview: nanoparticles and the immune system","volume":"151","author":"Zolnik","year":"2010","journal-title":"Endocrinology"}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946210000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946210000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T20:39:13Z","timestamp":1559594353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946210000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":141,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1350946210000558"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2010.08.002","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}